EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT)

Kevin J Whitehead iD, Doruk Toydemir iD, Whitney Wooderchak-Donahue, Gretchen M Oakley, Bryan McRae, Angelica Putnam, Jamie McDonald iD, Pinar Bayrak-Toydemir iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25147682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kevin J Whitehead und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Medicine, University of Utah, Salt Lake City, UT 84112, USA. Hauptthemen laut MEDLINE: Telangiectasia, Hereditary Hemorrhagic, Arteriovenous Malformations. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Utah, University of Utah, Center of Genomics Medicine, UGP Pilot Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Telangiectases and arteriovenous malformations (AVMs) are the characteristic lesions of Hereditary Hemorrhagic Telangiectasia (HHT). Somatic second-hit loss-of-function variations in the HHT causative genes, ENG and ACVRL1, have been described in dermal telangiectasias. It is unclear if somatic second-hit mutations also cause the formation of AVMs and nasal telangiectasias in HHT. To investigate the genetic mechanism of AVM formation in HHT, we evaluated multiple affected tissues from fourteen individuals. DNA was extracted from fresh/frozen tissue of 15 nasal telangiectasia, 4 dermal telangiectasia, and 9 normal control tissue biopsies, from nine unrelated individuals with HHT. DNA from six formalin-fixed paraffin-embedded (FFPE) AVM tissues (brain, lung, liver, and gallbladder) from five individuals was evaluated. A 736 vascular malformation and cancer gene next-generation sequencing (NGS) panel was used to evaluate these tissues down to 1% somatic mosaicism. Somatic second-hit mutations were identified in three in four AVM biopsies (75%) or half of the FFPE (50%) samples, including the loss of heterozygosity in ENG in one brain AVM sample, in which the germline mutation occurred in a different allele than a nearby somatic mutation (both are loss-of-function mutations). Eight of nine (88.9%) patients in whom telangiectasia tissues were evaluated had a somatic mutation ranging from 0.68 to 1.96% in the same gene with the germline mutation. Six of fifteen (40%) nasal and two of four (50%) dermal telangiectasia had a detectable somatic second hit. Additional low-level somatic mutations in other genes were identified in several telangiectasias. This is the first report that nasal telangiectasias and solid organ AVMs in HHT are caused by very-low-level somatic biallelic second-hit mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Telangiectasia, Hereditary HemorrhagicArteriovenous MalformationsHumansFemaleMaleMiddle AgedAdultEndoglinAgedMutationActivin Receptors, Type IITelangiectasisHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

AVMbiallelichereditary hemorrhagic telangiectasiasomatictelangiectasiatissue

Substanzen

EndoglinActivin Receptors, Type IIENG protein, humanACVRL1 protein, human

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Department of Medicine, University of Utah, Salt Lake City, UT 84112, USA.
  • HHT Center, Department of Radiology, University of Utah, Salt Lake City, UT 84112, USA.
  • School of Liberal Arts, Tulane University, New Orleans, LA 70118, USA.
  • Department of Pathology, University of Utah, Salt Lake City, UT 84112, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, UT 84112, USA.
  • ARUP Laboratories|Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84103, USA.

ORCID-Profile: Kevin J Whitehead, Doruk Toydemir, Jamie McDonald, Pinar Bayrak-Toydemir

Förderung

  • University of Utah
  • University of Utah, Center of Genomics Medicine, UGP Pilot Award

Zitieren

APA

Whitehead, K. J., Toydemir, D., Wooderchak-Donahue, W., Oakley, G. M., McRae, B., Putnam, A., McDonald, J., & Bayrak-Toydemir, P. (2024). Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT). International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147682

Vancouver

Whitehead KJ, Toydemir D, Wooderchak-Donahue W, Oakley GM, McRae B, Putnam A, et al. Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT). International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147682

BibTeX
@article{Whitehead2024,
  author = {Whitehead, Kevin J and Toydemir, Doruk and Wooderchak-Donahue, Whitney and Oakley, Gretchen M and McRae, Bryan and Putnam, Angelica and McDonald, Jamie and Bayrak-Toydemir, Pinar},
  title = {Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT)},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25147682}
}
Kostenlos starten →